Bharat Serums and Vaccines Limited (BSV) is investing Rs 200 crore to build a specialty injectables manufacturing facility in Hyderabad. The facility, which will be located in Genome Valley, will cater to both domestic and international markets. The first phase of the project is expected to be ready for production in early 2026.